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Abstract 
Our study evaluates the long-term effect of
microalbuminuria  on  mortality  among
patients with acute myocardial infarction. We
followed  151  patients  from  1996  to  2007  to
investigate if microalbuminuria is a risk fac-
tor  in  coronary  heart  disease.  All  patients
admitted with acute myocardial infarction in
1996 were included. At baseline, we recorded
urinary  albumin/creatinine  concentration
ratio,  body  mass  index,  blood  pressure,  left
ventricle  ejection  fraction  by  echocardiogra-
phy,  smoking  status,  medication,  diabetes,
age, and gender. Deaths were traced in 2007
by  means  of  the  Danish  Personal
Identification  Register.  Microalbuminuria,
defined as a urinary albumin/creatinine con-
centration  ratio  above  0.65  mg/mmoL,
occurred in 50% of the patients and was asso-
ciated  with  increased  all-cause  mortality.
Thus, 68% of the patients with microalbumin-
uria  versus  48%  of  the  patients  without
microalbuminuria  had  died  during  the  10
years of follow-up (P=0.04). The crude hazard
ratio for death associated with microalbumin-
uria  was  1.78  (CI:  1.18-2.68)  (P=0.006),
whereas the gender- and age-adjusted hazard
ratio  was  1.71  (CI:  1.03-2.83)  (P=0.04).  We
concluded that microalbuminuria in hospital-
ized patients with acute myocardial infarction
is prognostic for increased long-term mortali-
ty. We recommend measurement of microalbu-
minuria to be included as a baseline risk fac-
tor in patients with acute myocardial infarc-
tion and in future trials in patients with cor-
onary heart disease.
Introduction
A  subclinical  elevation  of  urinary  albumin
excretion, that is, microalbuminuria, has been
associated  with  an  increased  risk  of  cardiac
morbidity and mortality in reported population
studies.
1-5 Microalbuminuria  was  first  intro-
duced as a risk factor for chronic renal failure
among patients with diabetes,
6,7 and later was
found  to  reflect  systemic  vascular  damage.
8,9
Furthermore, microalbuminuria was correlated
with left ventricular wall thickness independent
of blood pressure.
10 Previously we reported an
increased prevalence of microalbuminuria in
patients with acute myocardial infarction.
10 In
the present report we have analyzed 10-year fol-
low-up results in the previously studied cohort
in  order  to  further  evaluate  the  association
between the risk of death in patients with acute
myocardial infarction and microalbuminuria.
Materials and Methods
In  1996,  250  Caucasian  individuals  were
admitted  to  Hvidovre  University  Hospital,
Department of Cardiology, with acute myocar-
dial infarction. The diagnosis was based on the
presence  of  chest  pain,  electrocardiographic
alterations,  and  significant  elevations  of  cor-
onary enzymes. Patients who died during admis-
sion were excluded as were patients who under-
went acute percutaneous coronary intervention
or coronary artery bypass grafting, as such inter-
ventions would probably overrule any prognostic
effect of microalbuminuria. In addition, patients
with known renal or urinary tract disease were
excluded. In total, 151 of the eligible patients
could be included in the primary study,
10 all of
whom gave informed consent. The study was in
accordance with the Helsinki II Declaration and
approved by the local ethics committee. 
On the day of discharge (about one week after
admission),  the  patients  provided  an  early
morning urine specimen. Urinary albumin con-
centration  was  measured  using  an  enzyme-
linked immunosorbent assay (ELISA).
11 Urinary
creatinine concentration was measured using
an  enzymatic  colorimetric  method.  The  albu-
min/creatinine concentration ratio was taken as
an  index  of  the  albumin  excretion  rate  in
urine.
12 In  accordance  with  previous  studies,
microalbuminuria  was  defined  as  a  urinary
albumin/creatinine  concentration  ratio  above
0.65 mg/mmoL.
2 The left ventricle ejection frac-
tion was estimated as a percentage by the wall
motion  index  using  the  nine-segment  model
multiplied by 30.
13 A Vingmed echocardiograph
model CFM 750 (Norway) was used. Blood pres-
sures were measured using a standard mercury
sphygmomanometer and an appropriately sized
cuff.  The  body  mass  index  was  calculated  as
weight  divided  by  height  squared  (kg/m
2).
Information about smoking status, presence of
diabetes,  and  medication  at  discharge  were
obtained  from  patient  records.  In  2007,  the
patients were traced by means of the Danish
Personal Identification Register. Data are given
as means, geometric means, or proportions with
95% confidence intervals. Differences in mean
values between the groups were tested using the
t-test for unpaired comparisons. The effect of
microalbuminuria and other baseline variables
on mortality was analyzed by the Cox proportion-
al hazards regression analysis and expressed as
a hazard ratio. All analyses were performed with
the  SPSS  14.0  computer  package.  A  value  of
P<0.05 was considered significant.
Results
The  baseline  characteristics  of  patients
with acute myocardial infarction with or with-
out  microalbuminuria  are  given  in  Table  1.
The  patients  with  microalbuminuria  were
older and had a lower body mass index. There
were  no  statistically  significant  differences
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found  in  gender,  systolic  or  diastolic  blood
pressure, left ventricle ejection fraction, smok-
ing status, or diabetes. After a 10-year follow-
up, 52% of the patients with normoalbumin-
uria were still alive, whereas only 32% of the
patients with microalbuminuria were (Figure
1). The hazard ratio for death associated with
microalbuminuria  was  1.78  (1.18-2.68)
(P=0.006).  Adjusted  for  age  and  gender,
microalbuminuria was associated with mortal-
ity  with  a  hazard  ratio  of  1.71  (1.03-2.83)
(P=0.04). As shown in Table 2, microalbumin-
uria was associated with a similar risk of death
as a left ventricle ejection fraction below 40%.
Conversely, diabetes, hypertension, smoking,
or male gender had no impact on mortality, and
high  body  mass  index  was  associated  with
enhanced survival.
Discussion
Microalbuminuria is an established predic-
tor  of  coronary  heart  disease  in  diabetic
patients as well as in non-diabetic healthy per-
sons.
2-4,11,14-19 In  this  study  we  confirm  that
microalbuminuria is strongly associated with
an increased hazard of mortality in patients
with acute myocardial infarction. Even though
the study population consisted of 151 patients
only, we were able to show that microalbumin-
uria significantly increases the risk of death,
independently  of  age  and  gender.  Thus,
microalbuminuria is a very strong and robust
risk  indicator  among  patients  with  acute
myocardial  infarction.  This  observation  con-
firms  and  extends  previous  observations  by
our group.
20
The finding in our present study could like-
ly be explained by more extensive vascular dis-
ease, for example, atherosclerosis, in patients
with microalbuminuria. This is supported by
other studies in which the severity of carotid
atherosclerosis, measured ultrasonographical-
ly, was correlated with urinary albumin excre-
tion.
21-23 Moreover, the link between microalbu-
minuria and atherosclerosis is confirmed by
the fact that half of the patients included in our
study had microalbuminuria, as defined by a
urinary  albumin  excretion  above  the  upper
10% range in the background population.
2 In
our study we used spot urines, not timed urine
collections. However, calculation of the albu-
min/creatinine  ratio  yields  an  acceptable
measure of the urinary albumin excretion rate
in  terms  of  specificity  and  sensitivity  when
screening for microalbuminuria.
12
The definition of microalbuminuria in dia-
betology was based originally on the level of
urinary  albumin  excretion  above  which  the
risk of chronic renal failure, but not of athero-
sclerotic  cardiovascular  disease,  was
increased;
24 that is, an albumin excretion rate
above  30  mg/day  or  an  albumin/creatinine
ratio  above  2  mg/mmoL.  In  addition,  it  has
become evident that the risk of atherosclerotic
cardiovascular  disease  is  increased  at  even
lower levels of urinary albumin excretion in
diabetic as well as non-diabetic subjects.
17,25-27
We used our previous definition of microalbu-
minuria, for example, a urinary albumin/ crea-
tinine  ratio  above  0.65  mg/mmoL,  which  in
non-diabetic subjects independently increases
the risk of atherosclerotic cardiovascular dis-
ease  without  additional  gain  in  risk  with
increasing values.
2,28
We  concluded  that  microalbuminuria  is
associated with impaired survival in patients
hospitalized  with  myocardial  infarction.
Microalbuminuria may be useful for risk strat-
ification  in  these  patients  and,  moreover,
should be included as a baseline variable in
intervention trials.
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